PIN11 A RETROSPECTIVE EVALUATION OF THE MANAGEMENT AND OUTCOME IN HOSPITALIZED PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA IN AN INNER-CITY HOSPITAL  by Sakalis, E et al.
A59Abstracts
PIN11
A RETROSPECTIVE EVALUATION OF THE MANAGEMENT
AND OUTCOME IN HOSPITALIZED PATIENTS WITH
COMMUNITY ACQUIRED PNEUMONIA IN AN INNER-CITY
HOSPITAL
Sakalis E1, Pan L2, Wong SL3
1Bellevue Hospital Center, New York, NY, USA; 2Ludwig Institute For
Cancer Research, New York, NY, USA; 3Pﬁzer Inc, Syosset, NY, USA
Community-acquired pneumonia (CAP) is a common and
serious illness. Analyses of administrative data show that large
variations exist in admission rates, length of hospital stay, and
use of institutional resources. OBJECTIVES: This study evalu-
ated the medical management of patients hospitalized with Com-
munity Acquired Pneumonia (CAP) in an urban inner-city public
hospital. The study was undertaken to identify areas for quality
improvement. METHODS: A retrospective chart review was
used to collect data on patients admitted to the hospital with a
diagnosis of CAP during the period January 1, 2003 to April 30,
2004. Data were collected based on American Thoracic Society
(ATS) criteria. RESULTS: Medical records of 155 patients were
reviewed; overall mortality rate was 4%; 80% of patients
received their ﬁrst antibiotic dose in less than eight hours; 97%
of patients had their oxygenation checked within 24 hours of
admission. Only 45% of patients had at least one culture per-
formed prior to initiation of antibiotics. The most commonly
prescribed antibiotic was levoﬂoxacin, representing 39% of all
antibiotic orders. Using the ATS guidelines, 14 (9%) patients
were considered to have received inappropriate antimicrobial
treatment. Of these patients, 7 had severe cases of CAP requir-
ing admission to an intensive care unit (ICU). The average length
of stay for all patients was 7.64 days (SD + 0.327). Patients who
received an antibiotic regimen that covered both typical and
atypical organisms, as compared to those who did not, had a
shorter length of therapy (7.33 days vs. 9.79 days, p < 0.05).
CONCLUSION: Ongoing analysis of inpatients with CAP will
provide information to evaluate improvement of clinical out-
comes and to identify areas of focus for future performance
improvement activities.
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OBJECTIVES: To evaluate the effect of drotegogin alfa (DA) on
bleeding events in patients with severe sepsis and multiple organ
failures. METHODS: A pre-post design was conducted before
and after DA’s market introduction. An optimal propensity score
matching method was undertaken to control for unbalanced
characteristics. Several models were tested to explain the number
of bleedings events. The more usual ones are the Poisson and the
negative binomial (NB) models. Contrary to the NB model,
including a dispersion parameter, the Poisson model supposes the
mean equals the variance. An alternative consists on modeling
separately the probability of experiencing at least one bleeding
(with a binomial model) and the number of bleeding events (with
a count model). Double-hurdle models suppose that, once a
threshold has been exceeded, patients experience at least one
bleeding event. In zero inﬂated models, both models can predict
an event absence. Non-nested models were compared with the
Vuong statistic. RESULTS: The matched sample includes 840
patients. Bleeding events were experienced by 17.6% of patients,
13.6% in the before and 21.7% in the after phase (p = 0.0021).
The mean number of bleedings was higher in DA treated patients
(0.28 against 0.18, p = 0.0208). The standard NB model ﬁtted
better than the double-hurdle NB model (p < 0.0001) and was
similar to the zero-inﬂated NB model (p = 0.6815). We kept the
NB model, the simpler one. Moreover, the dispersion parameter
was signiﬁcant (p = 0.0013), favouring the NB to the Poisson
model. In this multivariate model, patients in the after phase
were still more at risk of experiencing bleeding events. Other risk
factors included the presence of a central catheter infection and
a high LODS score. CONCLUSIONS: DA use in addition to the
conventional treatment leads to more bleeding events. In our
study, over-parameterised models did not bring more informa-
tion than simpler ones.
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OBJECTIVES: To evaluate the share of antibiotic therapy cost
in total treatment costs for nosocomial and community acquired
infections. METHODS: Systematic literature search
(1996–2003) using the major online databases and additional
manual search yielded 1211 references (selection Ia). Studies
were divided up to 11 different diagnostic groups that were con-
sidered to be most relevant (selection Ib). Inclusion and exclu-
sion criteria were applied for the selection Ic. Study quality was
assessed with a consolidated quality score comprising 23 ques-
tions. A study was assessed as “qualiﬁed” for further analyses,
if at least 50% of maximum points were achieved in a review
conducted by two independent reviewers. This resulted in the
selection of 44 studies (selection II) that were subject to a detailed
metaanalysis. RESULTS: The percentage of antibiotic costs in
relation to total direct costs was low: nosocomial pneumonia (N
= 3, 1.4–13.7%, SD: 5.5), respiratory tract infections (N = 2,
10–24.8%, SD: 5.3), community acquired pneumonia (N = 14,
0.64–57.84%, SD: 24.65), chronic bronchitis (N = 6,
1.1–66.66%, SD: 17.19), urinary tract infection (N =
3.5–33.82%, SD: 14.85), intraabdominal infection (N = 2,
3.2–19.38%, SD: 5.26), surgical prophylaxis (N = 2, 0.1–83.8%,
SD: 33.02), otolaryngological infections (N = 4, 14.18–60.1%),
STD (N = 1, 0.15–3.3%, SD: 2.23), Helicobacter pylori infec-
tions (N = 3, 2.34–45.49%, SD: 16.36), Clostridium difﬁcile
infections (N = 3, 0.07–1.20%, SD: 0.51). CONCLUSIONS:
This review showed that costs of antibiotic treatment were low
compared to overall direct treatment costs for most frequent
infections regardless of the differences in design and quality of
studies. The experience from this review may also contribute to
further development of evidence-based guidelines for conducting
pharmacoeconomical studies.
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